Gufic Biosciences Limited (NSE:GUFICBIO)
India · Delayed Price · Currency is INR 294.20
+6.60 (2.29%)
May 6, 2026, 3:29 PM IST
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 28.79 billion as of May 6, 2026. Its market cap has decreased by -15.93% in one year.
Market Cap
28.79B
Enterprise Value
31.60B
Revenue
8.97B
Ranking
n/a
PE Ratio
57.54
Stock Price
294.20
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 28.79B, an increase of 7,961.67%. That is a compound annual growth rate of 19.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 29.38B | -12.99% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 48.32B |
| Sun Pharma Advanced Research Company | 45.34B |
| RPG Life Sciences | 39.97B |
| Orchid Pharma | 31.91B |
| Solara Active Pharma Sciences | 25.00B |
| Indoco Remedies | 19.56B |
| Windlas Biotech | 18.09B |
| Sakar Healthcare | 14.52B |